FDA Approves Linagliptin for Type 2 Diabetes : Hospitalist News
Links shared publicly online about this topic.
- 322total visits
FDA Approves Linagliptin for Type 2 Diabetes : Hospitalist News
View full resource at ehospitalistnews.com
Tags: Heart, Endocrinology, Diabetes, Type 2 Diabetes, FDA, Critical Care, News, Hospitalist
Most Recently Shared on May 2, 2011 at 10:15 pm By:
RT @MedicalNewsNet: FDA Approves Linagliptin for Type 2 #Diabetes http://bit.ly/joNvsU
Also Shared By:
FDA Approves Linagliptin/Metformin Combo For Type 2 Diabetes : Family Practice News
familypracticenews.com — “FDA Approves Linagliptin/Metformin Combo For Type 2 Diabetes : Family Practice News” View full resource at familypracticenews.com
Most Recently Shared on January 31, 2012 at 6:18 pm By:
Damian McNamara Health Communicator
RT @FamilyPracNews: FDA Approves Linagliptin/Metformin Combo For Type 2 Diabetes http://t.co/4OQFJBli
Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes
news-medical.net — “Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin.” View full resource at news-medical.net
Most Recently Shared on January 31, 2012 at 12:29 pm By:
Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes: Boehringer Ingelheim P... http://t.co/QrEPkXXO
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on May 3, 2011 at 5:12 pm By:
FDA approves new drug for type 2 diabetes: Linagliptin, which can be used alone or in combination with other the... http://bit.ly/jPApJQ
Tradjenta Approved for Type 2 Diabetes - MPR
empr.com — “Boehringer Ingelheim and Eli Lilly announced that the FDA has approved Tradjenta (linagliptin tablets), a dipeptidyl peptidase-4 (DPP-4) inhibitor, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.” View full resource at empr.com
Most Recently Shared on May 3, 2011 at 2:38 pm By:
MPR News: Tradjenta Approved for Type 2 Diabetes: Boehringer Ingelheim and Eli Lilly announced that the FDA has ... http://bit.ly/iYELgu
Advertisement
Damian McNamara
@MedReporter
RT @FamilyPracNews: FDA Approves Linagliptin/Metformin Combo For Type 2 Diabetes http://t.co/4OQFJBli
1 year ago...